20170821-三星证券-Samsung_Healthcare_Weekly_16页_1mb
报告摘要
Sector Update Summary
Core Team Members
- Brian Lee - Team Head (Pharm/Biotech), Email: brian79.lee@samsung.com, Phone: 822 2020 7177
- SunYoung Yoon - Analyst (Pharm/Biotech), Email: sy85.yoon@samsung.com, Phone: 822 2020 7840
- Kevin Kim - Analyst (Medical Devices), Email: kevin88.kim@samsung.com, Phone: 822 2020 7178
- Wonyong Park - Research Associate, Email: wkrw.park@samsung.com, Phone: 822 2020 7847
Compliance Notice
- This report has been prepared without any undue external influence or interference, and accurately reflects the views of the analyst(s) covering the company or companies herein.
Date
- 2017.8.21
Global Healthcare Indices
| Country | Index | Forward P/E (x) | Portion of Market Cap (%) | 1-w (%) | 1-m (%) | 3-m (%) | ytd (%) |
|---|---|---|---|---|---|---|---|
| Korea | KRX Health Care | 35.4 | 5.3 | 3.4 | (1.3) | 6.5 | 7.3 |
| Korea | Kospi Medical Supplies | 46.7 | 2.5 | 1.7 | (0.4) | 12.3 | 24.9 |
| Korea | Kosdaq Pharmaceuticals | 27.0 | 2.2 | 3.5 | (2.5) | 5.0 | 2.4 |
| Korea | Kosdaq Medical and Precision Machines | 14.9 | 0.4 | 3.3 | 0.3 | 1.7 | (5.9) |
| US | S&P 500 Healthcare | 16.8 | 8.6 | (0.8) | (3.8) | 4.0 | 13.0 |
| US | S&P 500 Pharma/Biotech | 15.9 | 5.1 | (1.2) | (4.0) | 4.1 | 10.1 |
| US | Nasdaq Biotechnology | 44.3 | 2.4 | (0.9) | (6.4) | 4.7 | 14.7 |
| US | S&P 500 Healthcare equipment and services | 18.3 | 3.4 | (0.2) | (3.4) | 4.0 | 17.9 |
| Europe | MSCI Europe Healthcare | 16.2 | 11.0 | 0.5 | (4.2) | (9.2) | 0.3 |
| Europe | MSCI Europe Pharm/Bio | 15.7 | 9.4 | 0.5 | (4.2) | (9.3) | 0.4 |
| Europe | MSCI Europe Healthcare Equipment and Services | 22.0 | 1.6 | 0.9 | (4.3) | (7.6) | (0.1) |
| Japan | MSCI Japan Healthcare | 24.1 | 7.0 | (1.2) | (1.9) | (1.8) | 0.7 |
| Japan | MSCI Japan Pharm/Bio | 23.7 | 5.0 | (1.3) | (2.5) | (3.2) | (0.9) |
| Japan | Topix Pharma | 23.6 | 4.6 | (1.1) | (2.4) | (2.7) | 0.3 |
| Japan | MSCI Japan Healthcare Equipment and Services | 25.2 | 2.0 | (0.9) | (0.5) | 1.8 | 4.5 |
| China | MSCI China Healthcare | 18.5 | 1.6 | 0.4 | (3.2) | (1.6) | 17.4 |
| India | MSCI India Healthcare | 23.5 | 5.4 | 0.6 | (14.9) | (16.1) | (16.4) |
Key Insights
- The global healthcare sector showed mixed performance across different indices.
- The US S&P 500 Healthcare equipment and services index had a positive ytd performance of 13.0%.
- The MSCI Europe Healthcare Equipment and Services index had a negative ytd performance of (0.1)%.
- The MSCI India Healthcare index had a significant negative ytd performance of (16.4)%.
- The Korean healthcare indices showed varied performance, with the Kospi Medical Supplies index having a positive 3-m performance of 12.3%.
- The Kosdaq Medical and Precision Machines index had a negative ytd performance of (5.9)%.
- The MSCI Japan Healthcare Equipment and Services index had a positive ytd performance of 4.5%.
Korean Healthcare Firms Performance
Pharmaceutical Holdings
- Hanmi Science: 1-w: 8.4%, 1-m: 0.6%, 3-m: 23.7%, ytd: (14.0)%
- Green Cross Holdings: 1-w: (1.9)%, 1-m: (1.4)%, 3-m: (7.4)%, ytd: 29.8%
- Daewoong: 1-w: (2.6)%, 1-m: 16.0%, 3-m: 18.8%, ytd: (76.9)%
- Donga Socio Holdings: 1-w: 1.6%, 1-m: 0.0%, 3-m: (9.6)%, ytd: (19.9)%
- JW Holdings: 1-w: (1.1)%, 1-m: 2.5%, 3-m: (15.7)%, ytd: (15.3)%
- Chongkundang Holdings: 1-w: (6.5)%, 1-m: 0.8%, 3-m: (3.6)%, ytd: (20.5)%
Pharmaceuticals
- Hanmi Pharm: 1-w: 6.5%, 1-m: (2.3)%, 3-m: 2.4%, ytd: 28.3%
- Yuhan: 1-w: (1.9)%, 1-m: (4.9)%, 3-m: (13.8)%, ytd: (14.1)%
- Green Cross: 1-w: (1.4)%, 1-m: 0.9%, 3-m: (4.8)%, ytd: (13.8)%
- Young Jin Pharm: 1-w: 2.7%, 1-m: (8.6)%, 3-m: (23.7)%, ytd: (15.7)%
- SK Chemicals: 1-w: 3.4%, 1-m: (0.6)%, 3-m: (14.6)%, ytd: (13.8)%
- Daewoong Pharm: 1-w: 2.2%, 1-m: 16.3%, 3-m: (3.1)%, ytd: (14.1)%
- Chong Kun Dang: 1-w: (3.2)%, 1-m: (9.5)%, 3-m: (17.6)%, ytd: (12.1)%
- Bukwang Pharm: 1-w: 1.2%, 1-m: 0.0%, 3-m: (12.4)%, ytd: (14.6)%
APIs
- Kolon Life Science: 1-w: 3.6(10.7)%, 1-m: (17.7)%, 3-m: (37.6)%, ytd: (14.1)%
- ST Pharm: 1-w: (0.7)%, 1-m: (9.9)%, 3-m: (22.0)%, ytd: (18.6)%
- Kyongbo Pharmaceutical: 1-w: (5.0)%, 1-m: (4.5)%, 3-m: (11.5)%, ytd: (15.4)%
- Estech Pharma: 1-w: 3.5(10.9)%, 1-m: (7.0)%, 3-m: (4.7)%, ytd: (23.7)%
- Daebong LS: 1-w: (5.0)%, 1-m: (10.2)%, 3-m: (12.6)%, ytd: (19.1)%
- CKD Bio: 1-w: (0.8)%, 1-m: (3.6)%, 3-m: (13.2)%, ytd: (14.3)%
- Hwail Pharm: 1-w: (3.6)%, 1-m: (12.4)%, 3-m: (15.4)%, ytd: (8.7)%
Industrial-Use Enzymes
- Amicogen: 1-w: 5.2(14.0)%, 1-m: (28.3)%, 3-m: (33.0)%, ytd: (14.1)%
- Genofocus: 1-w: 3.0(10.1)%, 1-m: (10.8)%, 3-m: (15.6)%, ytd: (10.3)%
Biosimilars
- Samsung Biologics: 1-w: 3.4%, 1-m: 4.8%, 3-m: 42.9%, ytd: 80.8%
- Celltrion: 1-w: (1.4)%, 1-m: (4.2)%, 3-m: (12.1)%, ytd: (13.4)%
- Celltrion Healthcare: 1-w: 5.1%, 1-m: (0.0)%, 3-m: (10.5)%, ytd: (14.1)%
Stem Cell Therapy
- Medipost: 1-w: 2.5%, 1-m: (1.4)%, 3-m: (10.1)%, ytd: (11.3)%
- Chabiotech: 1-w: 10.1%, 1-m: (2.0)%, 3-m: (8.1)%, ytd: (12.0)%
- Tego Science: 1-w: (1.9)%, 1-m: (4.3)%, 3-m: (4.7)%, ytd: (15.0)%
- Pharmicell: 1-w: (5.5)%, 1-m: (10.3)%, 3-m: (25.8)%, ytd: (19.9)%
- Anterogen: 1-w: (2.0)%, 1-m: (4.8)%, 3-m: (13.3)%, ytd: (13.7)%
- Kangstem Biotech: 1-w: (3.8)%, 1-m: (10.6)%, 3-m: (22.1)%, ytd: (18.0)%
- Corestem: 1-w: (3.3)%, 1-m: (10.3)%, 3-m: (24.7)%, ytd: (22.4)%
Immune Cell Therapy
- Green Cross Cell: 1-w: (1.4)%, 1-m: (4.3)%, 3-m: (10.1)%, ytd: (11.3)%
- JW Shinyak: 1-w: (2.0)%, 1-m: (8.6)%, 3-m: (10.2)%, ytd: (15.0)%
- Green Cross Lab Cell: 1-w: (6.0)%, 1-m: (3.7)%, 3-m: (13.1)%, ytd: (14.1)%
Molecular Diagnostics
- Seegene: 1-w: 0.9(16.9)%, 1-m: (21.1)%, 3-m: (27.2)%, ytd: (14.1)%
- Panagene: 1-w: 12.9%, 1-m: (4.7)%, 3-m: (16.3)%, ytd: (18.3)%
- Bioneer: 1-w: (2.0)%, 1-m: (13.9)%, 3-m: (32.2)%, ytd: (23.3)%
- MG MED: 1-w: (0.8)%, 1-m: (12.4)%, 3-m: (37.3)%, ytd: (30.8)%
Functional Foods
- Naturalendo Tech: 1-w: 27.9(145.4)%, 1-m: (17.7)%, 3-m: (26.9)%, ytd: (11.6)%
- Su-Heung: 1-w: 2.3%, 1-m: (3.9)%, 3-m: (14.0)%, ytd: (14.0)%
- Cell Biotech: 1-w: (1.4)%, 1-m: (4.2)%, 3-m: (11.6)%, ytd: (11.6)%
- SK Bioland: 1-w: 3.9%, 1-m: (3.6)%, 3-m: (17.8)%, ytd: (12.0)%
Beauty Care
- Medytox: 1-w: 4.0%, 1-m: (8.9)%, 3-m: (14.8)%, ytd: (14.8)%
- Hugel: 1-w: 5.9%, 1-m: (4.3)%, 3-m: (11.0)%, ytd: (14.0)%
- Caregen: 1-w: (1.4)%, 1-m: (4.2)%, 3-m: (13.4)%, ytd: (13.4)%
- Pharma Research Products: 1-w: (3.2)%, 1-m: (5.6)%, 3-m: (10.5)%, ytd: (16.4)%
- Humedix: 1-w: 2.8%, 1-m: (4.1)%, 3-m: (5.8)%, ytd: (5.8)%
Medical Devices
- Osstem Implant: 1-w: 14.1%, 1-m: 11.4%, 3-m: 28.7%, ytd: 14.5%
- Dentium: 1-w: 5.3%, 1-m: (13.6)%, 3-m: (18.8)%, ytd: (16.5)%
- Dio: 1-w: (1.1)%, 1-m: (5.4)%, 3-m: (8.8)%, ytd: (10.1)%
- Viewworks: 1-w: (1.1)%, 1-m: (5.6)%, 3-m: (16.5)%, ytd: (28.4)%
- Value Added Technology: 1-w: (0.5)%, 1-m: (1.4)%, 3-m: (8.4)%, ytd: (15.2)%
- InBody: 1-w: 2.7%, 1-m: (10.8)%, 3-m: (11.9)%, ytd: (4.1)%
- Interjo: 1-w: (0.8)%, 1-m: (5.4)%, 3-m: (10.5)%, ytd: (14.1)%
- JVM: 1-w: (0.5)%, 1-m: (5.7)%, 3-m: (11.9)%, ytd: (5.7)%
- Rayence: 1-w: 0.0%, 1-m: (5.8)%, 3-m: (10.3)%, ytd: (10.3)%
- Lutronic: 1-w: 4.3%, 1-m: (2.7)%, 3-m: (38.9)%, ytd: (63.2)%
- Sewoon Medical: 1-w: 0.0%, 1-m: (4.2)%, 3-m: (15.2)%, ytd: (16.7)%
- Hans Biomed: 1-w: (3.9)%, 1-m: (7.7)%, 3-m: (1.2)%, ytd: (14.1)%
- Huvitz: 1-w: (7.4)%, 1-m: (0.8)%, 3-m: (8.4)%, ytd: (12.6)%
- Corentec: 1-w: (1.5)%, 1-m: (5.4)%, 3-m: (7.8)%, ytd: (15.3)%
- Mediana: 1-w: (0.4)%, 1-m: (4.9)%, 3-m: (14.9)%, ytd: (5.4)%
- U&I Corporation: 1-w: (7.6)%, 1-m: (2.6)%, 3-m: (8.6)%, ytd: (16.4)%
- Hironic: 1-w: (4.8)%, 1-m: (9.4)%, 3-m: (17.7)%, ytd: (31.9)%
- CU Medical Systems: 1-w: (2.0)%, 1-m: (14.7)%, 3-m: (14.7)%, ytd: (14.7)%
Telemedicine
- Infinit Healthcare: 1-w: 2.7%, 1-m: (2.4)%, 3-m: (9.4)%, ytd: (4.2)%
- UBCare: 1-w: 5.9%, 1-m: (10.1)%, 3-m: (13.3)%, ytd: (13.3)%
展开完整摘要
试读结束，高清完整版pdf/doc/ppt,请点下载
